Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1990 Jan:4 Suppl 1:7-12.
doi: 10.1007/BF00053420.

Serotonergic antagonists and vascular disease

P M Vanhoutte  1
Affiliations
Review

Serotonergic antagonists and vascular disease

P M Vanhoutte. Cardiovasc Drugs Ther. 1990 Jan.

Abstract

5-Hydroxytryptamine (serotonin) can evoke both contraction and relaxation of vascular smooth muscle. In disease, the constrictor component of the response to the monoamine appears to dominate. 5HT2-serotonergic antagonists favor dilatation, not only because they block the activating effect of serotonin on vascular smooth muscle, but also because they unmask the (endothelium-dependent) relaxation to the monoamine and brake the amplifying effect that it exerts on platelet aggregation. These properties of serotonergic antagonists help to explain their protective effects in vascular disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Circ Res. 1987 Aug;61(2):256-70 - PubMed
    1. J Pharmacol Exp Ther. 1981 Jul;218(1):217-30 - PubMed
    1. Circ Res. 1986 Jun;58(6):783-9 - PubMed
    1. J Cardiovasc Pharmacol. 1984;6 Suppl 4:S564-74 - PubMed
    1. Circ Res. 1989 May;64(5):900-14 - PubMed

Substances

LinkOut - more resources